Impact of the DASH4D Diet on Glycemic Biomarkers in Adults with Type 2 Diabetes: Insights from a Randomized Controlled Feeding Trial
Highlight
- The DASH4D diet, adapted specifically for type 2 diabetes, significantly reduced fructosamine, fasting glucose, and HbA1c levels over 5 weeks.
- The controlled feeding randomized trial included 101 adults with type 2 diabetes, predominantly Black and older adults, enhancing the study’s clinical relevance.
- Findings support the DASH4D dietary approach as an effective glycemic management tool in type 2 diabetes, with implications for clinical dietary counseling.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.